FDA Drug recall D-1462-2019
Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30
- FDA Drug
- Class II
- terminated
- Published 2019-07-17
On 2019-07-17 the FDA classified a Class II recall of Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30 by Golden State Medical Supply, citing CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1462-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-06-14 |
| Published | 2019-07-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Golden State Medical Supply |
| Distribution | US |
Product
Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30
Reason
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Identifiers
| code_info | Lot #: GS017479, Expiration 01/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1462-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.